Held by 1 specialist biotech fund
Signal Note: Deerfield Exit from ACCO Brands
This exit is immaterial to biotech analysis—ACCO Brands (NYSE: ACCO) is a office products/supplies company with no drug pipeline or clinical catalysts. Deerfield's exit likely reflects portfolio rebalancing or underperformance in a non-core holding rather than a biotech-specific signal.